Skip to search formSkip to main contentSkip to account menu

prothrombin complex concentrates

Known as: PPSB, cofact, factor IX concentrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Summary Prothrombin complex concentrates (PCC) can rapidly normalise prolonged prothrombin time, induced by vitamin K antagonists… 
2012
2012
In emergency/clinical practice it is often necessary to restore the balance of blood coagulation: the rapid reversal of oral… 
Review
2012
Review
2012
Prothrombin complex concentrates (PCCs) are purified drug products with hemostatic activity derived from a plasma pool. Today… 
2006
2006
BACKGROUND:  Proteomic technologies are evolving tools to analyze complex protein patterns that to date have been rarely applied… 
1996
1996
Summary Recent studies using assays for surrogate markers of thrombogenic-ity in man have demonstrated that activation of the… 
Highly Cited
1995
Highly Cited
1995
Summary Current in vitro tests for thrombogenicity of FIX concentrates used for prothrombin complex concentrates (PCCs), are of… 
Highly Cited
1991
Highly Cited
1991
Purer factor IX concentrates, containing very little or no factor II or X, have been developed in an attempt to avoid the… 
Highly Cited
1990
Highly Cited
1990
Prothrombin complex concentrates (PCC), licensed for the treatment of hemophilia B, are known to carry a significant risk of… 
1980
1980
Summary Prothrombin complex concentrates (PCC) are known to carry a risk of thromboembolism. We have chosen to reassess the… 
1978
1978
Nine patients with severe classic hemophilia and inhibitors against factor VIII were treated for 156 bleeding episodes with 503…